Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1563-1569

  McQuarrie, Emily P ^a   Shakerdi, Loai ^b   Jardine, Alan G ^a   Fox, Jonathan G ^b   MacKinnon, Bruce ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

IgG; outcome; prediction; progression; proteinuria

Indexed keywords

ALBUMIN; CREATININE; IMMUNOGLOBULIN G;

ACCURACY; ADULT; ALBUMINURIA; AREA UNDER THE CURVE; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MICROALBUMINURIA; MORTALITY; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; URINALYSIS;

ADULT; ALBUMINS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; IMMUNOGLOBULIN G; MALE; PROGNOSIS; PROTEINURIA; ROC CURVE; SURVIVAL RATE;

EID: 79955581606     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq605     Document Type: Article

References (17)

1. Perico N, Benigni A, Remuzzi G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008; 7: 936-953
2. Taal MW, Brenner BM. Renal risk scores: progress and prospects. Kidney Int 2008; 73: 1216-1219 (Pubitemid 351693152)
3. Ruggenenti P, Perna A, Remuzzi G. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 2003; 63: 2254-2261 (Pubitemid 36605839)
4. Brenner BM, Cooper ME, de Zeeuw D et al. RENAAL Study Inves-tigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl JMed 2001; 345: 861-869
5. Mackinnon B, Shakerdi L, Deighan CJ et al. Urinary transferrin, high molecular weight proteinuria and the progression of renal disease. Clin Nephrol 2003; 59: 252-258 (Pubitemid 36503544)
6. Branten AJ, du Buf-Vereijken PW, Klasen IS et al. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic mem-branous nephropathy: a validation study. JAm Soc Nephrol 2005; 16: 169-174 (Pubitemid 43073169)
7. Bazzi C, Petrini C, Rizza V et al. Urinary excretion of IgG and alpha (1)-microglobulin predicts clinical course better than extent of protein-uria in membranous nephropathy. Am JKidney Dis 2001; 38: 240-248
8. Bazzi C, Rizza V, Raimondi S et al. In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppres-sion. Clin JAm Soc Nephrol 2009; 4: 929-935
9. Bazzi C, Petrini C, Rizza V et al. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glo-merulosclerosis: a pilot study. Am JKidney Dis 2003; 41: 328-335 (Pubitemid 36152450)
10. Guasch A, Deen WM, Myers BD. Charge selectivity of the glomeru-lar filtration barrier in healthy and nephrotic humans. J Clin Invest 1993; 92: 2274-2282 (Pubitemid 23333533)
11. Abbate M, Zoja C, Remuzzi G How does proteinuria cause progres-sive renal damage? JAm Soc Nephrol 2006; 17: 2974-2984 (Pubitemid 44707757)
12. Morais C, Westhuyzen J, Metharom P et al. High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells. Nephrol Dial Transplant 2005; 20: 50-58 (Pubitemid 40207607)
13. Reichert LJ, Koene RA, Wetzels JF Urinary IgG excretion as a prog-nostic factor in idiopathic membranous nephropathy. Clin Nephrol 1997; 48: 79-84 (Pubitemid 27371035)
14. Bazzi C, Petrini C, Rizza V et al. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glo-merulosclerosis: apilot study. Am JKidney Dis 2003; 41: 328-335 (Pubitemid 36152450)
15. Deegens JK, Wetzels JF. Fractional excretion of high-and low-mo-lecular weight proteins and outcome in primary focal segmental glo-merulosclerosis. Clin Nephrol 2007; 68: 201-208 (Pubitemid 47527439)
16. Bazzi C, Rizza V, Paparella M et al. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibi-tors in IgA nephropathy. J Nephrol 2009; 22: 387-396
17. du Buf-Vereijken PW, Wetzels JF Treatment-related changes in urin-ary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency Nephrol Dial Transplant 2006; 21: 389-396 (Pubitemid 43159993)